Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acid, ALDX, allergic, atherogenic, auction, baseline, bid, bile, bridge, Care, Chapter, chemotherapeutic, CHMP, cholesterol, Congenita, content, density, entry, experiencing, fat, GILD, HBV, Horse, imaging, immunogenic, immunogenicity, inactivation, inclusive, infection, Journal, launch, lipoprotein, loan, magnetic, Mirum, month, MRK, Pachyonychia, people, Pneumosil, pradefovir, profile, proton, published, pursing, relief, renal, repaid, resonance, Respiratory, silent, Stalking, successful, Veklury, VRNA, wound, Xintong
Removed:
accepted, age, announcement, breast, cancer, close, collaboration, commencing, consecutive, convert, delayed, essentially, Europe, evaluating, fiscal, governing, half, indenture, judgement, lasofoxifene, locally, metastatic, multiply, mutation, mutual, notice, occurrence, pay, percentage, preceding, reduced, reference, seeking, Sermonix, sparsentan, tied, women
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view